Compare Adaptive Biotechnologies Corp (ADPT) vs Bank of Nova Scotia (BNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Bank of Nova Scotia — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Bank of Nova Scotia trades at $89.03 (market cap $108.32B). The key difference: Bank of Nova Scotia is far larger — about 26.8× Adaptive Biotechnologies Corp's market cap, and Bank of Nova Scotia pays a 3.64% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | BNS | |
|---|---|---|
Market Cap | $4.04B | $108.32B |
Sector | Health | Financials |
52-Week High | $25.45 | $90.29 |
52-Week Low | $12.30 | $56.41 |
Enterprise Value | $4.10B | — |
Dividend Yield | — | 3.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →
